- Home
- OPK vs SDGR Comparison
OPK vs SDGR Comparison
Compare OPK & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPK | SDGR |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 967.3M | 856.7M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OPK | SDGR |
|---|---|---|
| Price | $1.15 | $11.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $2.28 | ★ $24.33 |
| AVG Volume (30 Days) | ★ 2.7M | 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $713,142,000.00 | $207,539,000.00 |
| Revenue This Year | N/A | $23.92 |
| Revenue Next Year | N/A | $19.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $11.11 |
| 52 Week High | $2.04 | $27.63 |
Technical Indicators
Market Signals| Indicator | OPK | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 29.68 | 26.13 |
| Support Level | $1.11 | N/A |
| Resistance Level | $1.43 | $19.51 |
| Average True Range (ATR) | 0.03 | 0.62 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 2.67 | 5.65 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.